ANP Ann: Phase IIb DMD CTA submitted for trial conduct in Europe - 19th Dec 2022, 9:35am

annb0t

annb0t

Top 20
ANP Ann: Phase IIb DMD CTA submitted for trial conduct in Europe
Price Sensitive: N
Date: 19th Dec 2022, 9:35am

>>> Read announcement: Google: ANP Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
ANP Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK - 27th Jun 2023, 3:46pm
Replies
0
Views
94
annb0t
annb0t
annb0t
ANP Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial - 8th Jun 2023, 8:38am
Replies
0
Views
105
annb0t
annb0t
annb0t
ANP Ann: First approval for ATL1102 Phase IIb DMD clinical trial - 14th Feb 2023, 8:46am
Replies
0
Views
121
annb0t
annb0t
annb0t
ANP Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 31st Oct 2023, 9:38am
Replies
0
Views
94
annb0t
annb0t
annb0t
ANP Ann: Change in substantial holding - 17th Oct 2023, 2:11pm
Replies
0
Views
75
annb0t
annb0t
Top Bottom